Drug Delivery (Dec 2022)

Development of microparticles for oral administration of Periplaneta americana extract to treat ulcerative colitis

  • Meng Li,
  • Hao Wu,
  • Shuang Wang,
  • Shengshun Wu,
  • Jing Han,
  • Yang Han

DOI
https://doi.org/10.1080/10717544.2022.2112115
Journal volume & issue
Vol. 29, no. 1
pp. 2723 – 2733

Abstract

Read online

Ulcerative colitis (UC) is a chronic disease, which can result the inflammation of the rectum, mucosa of the colon, and submucosa. The active component such as polypeptide in Periplaneta americana, which is one of the most common insects in the nature, can be extracted to treat UC. However, the active components in Periplaneta americana extract (PAE) can be degraded in the stomach due to its extreme acidic environment and enzyme. In this study, we developed a pH-dependent drug delivery method using polymer cellulose acetate (Eudragit S100) as a carrier to deliver high concentration PAE to inflamed colon. Both in vitro and in vivo results showed the PAE-Eudragit-S100 could treat UC through delivering active drug components to colon without degradation.

Keywords